Cargando…

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted

INTRODUCTION: Calculating the cost per disability-adjusted life years (DALYs) averted associated with interventions is an increasing popular means of assessing the cost-effectiveness of strategies to improve population health. However, there has been no systematic attempt to characterize the literat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neumann, Peter J., Thorat, Teja, Zhong, Yue, Anderson, Jordan, Farquhar, Megan, Salem, Mark, Sandberg, Eileen, Saret, Cayla J., Wilkinson, Colby, Cohen, Joshua T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179084/ https://www.ncbi.nlm.nih.gov/pubmed/28005986 http://dx.doi.org/10.1371/journal.pone.0168512

Ejemplares similares

Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures
por: Neumann, Peter J., et al.
Publicado: (2018)

Adherence to the iDSI reference case among published cost-per-DALY averted studies
por: Emerson, Joanna, et al.
Publicado: (2019)

Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies
por: Leech, Ashley A., et al.
Publicado: (2018)

Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds
por: Daroudi, Rajabali, et al.
Publicado: (2021)

The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh
por: Teerawattananon, Yot, et al.
Publicado: (2016)

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs
por: Bilinski, Alyssa, et al.
Publicado: (2017)

Cost per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022
por: Mousavi, Idine, et al.
Publicado: (2022)

Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia
por: Thorat, Teja, et al.
Publicado: (2018)

Dalí --- Dalí --- Dalí
por: Dalí, Salvador, 1904-1989
Publicado: (1974)

Cost–DALY comparison of hip replacement care in 12 Belgian hospitals
por: Dehanne, Fabian, et al.
Publicado: (2021)

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study
por: Verguet, Stéphane, et al.
Publicado: (2017)

Global Patterns of QALY and DALY Use in Surgical Cost-Utility Analyses: A Systematic Review
por: Rios-Diaz, Arturo J., et al.
Publicado: (2016)

Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted
por: Thomas, Sara L., et al.
Publicado: (2017)

The burden of COVID-19 in French Guiana: Vaccine-averted deaths, hospitalizations and costs
por: Nacher, Mathieu, et al.
Publicado: (2023)

Dali
por: Moorhouse, Paul
Publicado: (1991)

The Cost of Nursing per Bed
Publicado: (1909)

Time to include burden of surgical injuries after disasters in the Global Surgery agenda? An assessment of DALYs and averted burden by surgery after the 2008 Wenchuan earthquake
por: Rodriguez-Llanes, Jose Manuel, et al.
Publicado: (2018)

Salvador Dalí
por: Rodríguez-Aguilera, Cesáreo
Publicado: (1980)

Salvador Dalí
por: Carmona, Angel, 1948-
Publicado: (1964)

Dali/Miró /
por: Walton, Paul H.
Publicado: (1967)

Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis
por: Jairath, Vipul, et al.
Publicado: (2022)

Burden of smoking on disease-specific mortality, DALYs, costs: the case of a high-income European country
por: Farcher, Renato, et al.
Publicado: (2023)

Dalí : genius, obsession, and lust /
por: Schiebler, Ralf
Publicado: (1996)

Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States
por: Chesson, Harrell W, et al.
Publicado: (2008)

Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018
por: Kim, David D., et al.
Publicado: (2020)

Dalí : lo crudo y lo podrido
por: Ramírez, Juan Antonio, 1948-
Publicado: (2002)

Dalí : la obra y el hombre
por: Descharnes, Robert
Publicado: (1989)

Correction to: Perspective and Costing in Cost‑Effectiveness Analysis, 1974–2018
por: Kim, David D., et al.
Publicado: (2020)

Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing
por: Wilkinson, Anna N., et al.
Publicado: (2023)

A Nighttime Telemedicine and Medication Delivery Service to Avert Pediatric Emergencies in Haiti: An Exploratory Cost-Effectiveness Analysis
por: Flaherty, Katelyn E., et al.
Publicado: (2022)

Dali server update
por: Holm, Liisa, et al.
Publicado: (2016)

Thomas F. Daly
Publicado: (1923)

Dalí : el final oculto de un exhibicionista
por: Carol, Márius
Publicado: (1990)

Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study
por: Savinkina, Alexandra, et al.
Publicado: (2022)

Averting Disease
Publicado: (1860)

Averting Disease
Publicado: (1876)

A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India
por: Royal, Abhishek, et al.
Publicado: (2022)

Healthcare resource utilization and costs among children with cystic fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

Accounting for the relationship between per diem cost and LOS when estimating hospitalization costs
por: Ishak, K Jack, et al.
Publicado: (2012)

Cost comparisons and factors related to cost per stay in intensive care units in Belgium
por: Bruyneel, Arnaud, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lb77u450f5sd2fp6sl9cadlm38